Ding Y - Search Results

1

Sequence-based drug design as a concept in computational drug design.

Chen L, Fan Z, Chang J, Yang R, Hou H, Guo H, Zhang Y, Yang T, Zhou C, Sui Q, Chen Z, Zheng C, Hao X, Zhang K, Cui R, Zhang Z, Ma H, Ding Y, Zhang N, Lu X, Luo X, Jiang H, Zhang S, Zheng M. Chen L, et al. Among authors: ding y. Nat Commun. 2023 Jul 14;14(1):4217. doi: 10.1038/s41467-023-39856-w. Nat Commun. 2023. PMID: 37452028 Free PMC article.

2

The N-terminal ubiquitin-binding region of ubiquitin-specific protease 28 modulates its deubiquitination function: NMR structural and mechanistic insights.

Wen Y, Shi L, Ding Y, Cui R, He WT, Hu HY, Zhang N. Wen Y, et al. Among authors: ding y. Biochem J. 2015 Oct 15;471(2):155-65. doi: 10.1042/BJ20150088. Epub 2015 Aug 12. Biochem J. 2015. PMID: 26268556

3

Structural and Functional Investigations of the N-Terminal Ubiquitin Binding Region of Usp25.

Yang Y, Shi L, Ding Y, Shi Y, Hu HY, Wen Y, Zhang N. Yang Y, et al. Among authors: ding y. Biophys J. 2017 May 23;112(10):2099-2108. doi: 10.1016/j.bpj.2017.04.022. Biophys J. 2017. PMID: 28538147 Free PMC article.

4

Structural and functional studies of USP20 ZnF-UBP domain by NMR.

Yang Y, Ding Y, Zhou C, Wen Y, Zhang N. Yang Y, et al. Among authors: ding y. Protein Sci. 2019 Sep;28(9):1606-1619. doi: 10.1002/pro.3675. Epub 2019 Aug 9. Protein Sci. 2019. PMID: 31278784 Free PMC article.

5

USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.

Wang H, Meng Q, Ding Y, Xiong M, Zhu M, Yang Y, Su H, Gu L, Xu Y, Shi L, Zhou H, Zhang N. Wang H, et al. Among authors: ding y. FEBS J. 2021 Feb;288(4):1325-1342. doi: 10.1111/febs.15461. Epub 2020 Jul 20. FEBS J. 2021. PMID: 32578360 Free article.

6

Aha1 Exhibits Distinctive Dynamics Behavior and Chaperone-Like Activity.

Hu H, Wang Q, Du J, Liu Z, Ding Y, Xue H, Zhou C, Feng L, Zhang N. Hu H, et al. Among authors: ding y. Molecules. 2021 Mar 30;26(7):1943. doi: 10.3390/molecules26071943. Molecules. 2021. PMID: 33808352 Free PMC article.

7

Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase.

Li W, Liao LP, Song N, Liu YJ, Ding YL, Zhang YY, Zhou XR, Sun ZY, Xiao SH, Wang HB, Lu J, Zhang NX, Jiang HL, Chen KX, Liu CP, Zheng J, Zhao KH, Luo C. Li W, et al. Acta Pharmacol Sin. 2022 Feb;43(2):470-482. doi: 10.1038/s41401-021-00653-0. Epub 2021 Apr 13. Acta Pharmacol Sin. 2022. PMID: 33850276 Free PMC article.

8

Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction.

Du D, Xu D, Zhu L, Stazi G, Zwergel C, Liu Y, Luo Z, Li Y, Zhang Y, Zhu K, Ding Y, Liu J, Fan S, Zhao K, Zhang N, Kong X, Jiang H, Chen K, Zhao K, Valente S, Min J, Duan W, Luo C. Du D, et al. Among authors: ding y. J Med Chem. 2021 Jun 24;64(12):8194-8207. doi: 10.1021/acs.jmedchem.0c02261. Epub 2021 Jun 2. J Med Chem. 2021. PMID: 34077206

9

High-Throughput-Methyl-Reading (HTMR) assay: a solution based on nucleotide methyl-binding proteins enables large-scale screening for DNA/RNA methyltransferases and demethylases.

Xiao S, Guo S, Han J, Sun Y, Wang M, Chen Y, Fang X, Yang F, Mu Y, Zhang L, Ding Y, Zhang N, Jiang H, Chen K, Zhao K, Luo C, Chen S. Xiao S, et al. Among authors: ding y. Nucleic Acids Res. 2022 Jan 25;50(2):e9. doi: 10.1093/nar/gkab989. Nucleic Acids Res. 2022. PMID: 34718755 Free PMC article.

10

Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1.

Zhu M, Wang H, Ding Y, Yang Y, Xu Z, Shi L, Zhang N. Zhu M, et al. Among authors: ding y. FASEB J. 2022 May;36(5):e22329. doi: 10.1096/fj.202101914RR. FASEB J. 2022. PMID: 35476303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,947 results

Search Page